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Abstract
Integrase is an essential retroviral enzyme, catalyzing the stable integration of reverse transcribed DNA into cellular DNA.
Several aspects of the integration mechanism, including the length of host DNA sequence duplication flanking the
integrated provirus, which can be from 4 to 6 bp, and the nucleotide preferences at the site of integration, are thought to
cluster among the different retroviral genera. To date only the spumavirus prototype foamy virus integrase has provided
diffractable crystals of integrase-DNA complexes, revealing unprecedented details on the molecular mechanisms of DNA
integration. Here, we characterize five previously unstudied integrase proteins, including those derived from the
alpharetrovirus lymphoproliferative disease virus (LPDV), betaretroviruses Jaagsiekte sheep retrovirus (JSRV), and mouse
mammary tumor virus (MMTV), epsilonretrovirus walleye dermal sarcoma virus (WDSV), and gammaretrovirus
reticuloendotheliosis virus strain A (Rev-A) to identify potential novel structural biology candidates. Integrase expressed
in bacterial cells was analyzed for solubility, stability during purification, and, once purified, 39 processing and DNA strand
transfer activities in vitro. We show that while we were unable to extract or purify accountable amounts of WDSV, JRSV, or
LPDV integrase, purified MMTV and Rev-A integrase each preferentially support the concerted integration of two viral DNA
ends into target DNA. The sequencing of concerted Rev-A integration products indicates high fidelity cleavage of target
DNA strands separated by 5 bp during integration, which contrasts with the 4 bp duplication generated by a separate
gammaretrovirus, the Moloney murine leukemia virus (MLV). By comparing Rev-A in vitro integration sites to those
generated by MLV in cells, we concordantly conclude that the spacing of target DNA cleavage is more evolutionarily flexible
than are the target DNA base contacts made by integrase during integration. Given their desirable concerted DNA
integration profiles, Rev-A and MMTV integrase proteins have been earmarked for structural biology studies.
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Introduction
Integrase (IN) is a key protein in the replicative cycle of
retroviruses, integrating reverse-transcribed linear viral DNA
(vDNA) into a chromosome of the infected host cell [1]. Retroviral
integration proceeds in four steps: (i) IN-vDNA binding to form
the stable synaptic complex or intasome, which is comprised of an
IN tetramer and the U3 and U5 ends of vDNA, (ii) 39 processing,
(iii) DNA strand transfer, and (iv) DNA gap repair. IN 39
processing activity in most cases cleaves two nucleotides from both
the U3 and U5 vDNA ends, generating reactive CAOH-39 end
sequences. In the DNA strand transfer step, IN uses the CAOH-39
ends to attack a pair of phosphodiester bonds that are separated on
opposing chromosomal target DNA strands by four to six
nucleotides, depending on the retrovirus. Gap repair of the
concerted DNA strand transfer reaction product yields a
duplication of 4–6 bp of target DNA flanking the integrated
provirus.
Retroviral IN proteins consist of three domains: the zinc-
binding N-terminal domain (NTD), the catalytic core domain that
contains the invariant D,D(35)E enzyme active site catalytic triad,
and the C-terminal domain (reviewed in [2]). Epsilonretrovirus,
gammaretrovirus, and spumavirus INs differ from the other
retroviral INs by the presence of a fourth domain, the N-terminal
extension domain, which precedes the NTD [3].
Major obstacles in the structural biology of retroviral IN
proteins include the propensity for protein aggregation under
conditions of limited ionic strength and the presence of flexible
linkers connecting the different protein domains [2]. Despite these
limitations, X-ray crystal structures of the spumavirus prototype
foamy virus (PFV) intasome that represent the salient nucleopro-
tein complexes along the first three steps in the integration
pathway have been determined [4–6]. These advances are in large
part due to favorable PFV IN biochemical properties, which
include highly soluble protein and the ability to efficiently integrate
two surrogate vDNA ends in concerted fashion into target DNA in
vitro [7,8]. The intasome structures provide unprecedented details
on the molecular mechanism of retroviral DNA integration as well
as the mechanisms of action of clinical strand transfer inhibitors
[4–6,9]. To date, only the PFV IN has yielded diffractable
intasome crystals. Our long-term goal is to increase the repertoire
of retroviral intasome structures. Toward this end, we have
characterized five previously unstudied retroviral IN proteins.
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The INs from the alpharetrovirus lymphoproliferative disease
virus (LPDV) [10], betaretroviruses Jaagsiekte sheep retrovirus
(JSRV) [11] and mouse mammary tumor virus (MMTV) [12],
epsilonretrovirus walleye dermal sarcoma virus (WDSV) [13], and
gammaretrovirus reticuloendotheliosis virus strain A (Rev-A) [14]
were expressed as hexahistidine (His6) fusion proteins in bacteria.
Here we examine the solubility of the proteins, their stability
during purification, and the ability for the purified proteins to
support IN activities in vitro under a variety of reaction conditions.
Our results show that WDSV IN is insoluble under the tested
conditions while JRSV and LPDV INs were unstable and
precipitated during protein purification. Purified, active MMTV
and Rev-A INs were by contrast obtained from bacterial cell
lysates. We show that both enzymes preferentially integrate two
vDNA ends under concerted integration reaction conditions.
Interestingly, our data reveal that gammaretroviral Rev-A and
MLV INs show very similar base preferences at the sites of
integration despite generating different lengths of duplicated target
DNA sequence.
Materials and Methods
Bacterial expression vectors and oligonucleotides
Most IN proteins were expressed from the pFVmarIN
derivative of bovine immunodeficiency virus (BIV) IN expression
vector pCPH6P-BIV-IN [15], which directs the synthesis of N-
terminal His6-tagged proteins followed by a cleavage site for
human rhinovirus (HRV) 3C protease; LPDV IN was by contrast
expressed from pRSET-A (Life Technologies, Grand Island, NY)
as a His6 fusion protein. The following DNAs were used as PCR
templates: JSRV, pCMV2JS21 [16]; WDSV, pDL1 [17]; MMTV,
pMMTV-HP [12]; Rev-A, pSW253 [14]. The JSRV IN sequence
amplified by PCR using primers AE4484 and AE4485 (see Table
1 for a list of oligonucleotides used in this study) was cleaved with
XmaI and BglII, and the cut DNA was ligated to XmaI/BamHI-
digested pFVmarIN; WDSV and MMTV IN sequences were
similarly introduced into the pFVmarIN backbone. The Rev-A IN
sequence amplified using primers AE4506 and AE4507 was
cleaved with NdeI and BglII and ligated with NdeI/BamHI-
digested pFVmarIN. The LPDV IN reading frame, which was
synthesized de novo (Life Technologies), was cut with BamHI and
XhoI, and then ligated to BamHI/XhoI-digested pRSET-A. The
sequences of IN reading frames were verified by dideoxy
sequencing.
Protein expression and purification
Escherichia coli strain PC2 [15] carrying the various IN expression
constructs was grown in LB broth in the presence of 40 mM
ZnSO4. Optimal expression conditions based on the temperature
(18uC, 25uC, 30uC, or 37uC) and time (4 h, 6 h, or 12 h) of
induction, as well as the concentration (0.1 mM, 0.3 mM,
0.5 mM, or 1 mM) of the chemical isopropyl-b-D-thiogalactopyr-
anoside (IPTG) inducer, were independently established for each
IN.
Induced bacterial cultures were harvested by centrifugation at
6,000 X g, and pellets were dissolved in buffer A (20 mM HEPES,
pH 7.6, 200 mM NaCl, 1 mM phenylmethanesulfonylfluoride
[PMSF]). Following sonication for 1.5 min at 50 mA, the cell
lysate was centrifuged at 60,000 X g for 45 min. The resulting S1
supernatant fraction was saved, and the P1 pellet was resuspended
in buffer B (20 mM HEPES, pH 7.6, 1 M NaCl, 5 mM 3-{[3-
cholamidopropyl] dimethylammonio}-2-hydroxy-1-propanesulfo-
nate [CHAPS], 1 mM PMSF) by homogenization. Supernatant
fractionation S2 was saved following centrifugation, while pellet P2
was resuspended by homogenization in buffer C (20 mM HEPES,
pH 7.6, 0.5 M NaCl, 2 M urea, 1 mM PMSF). Final S3 and P3
fractions were made after centrifugation. Fractions were analyzed
by western blot using anti-His6 monoclonal antibody conjugated
to horseradish peroxidase (Clontech, Mountain View, CA) at
1:10,000 dilution.
LPDV and JSRV IN S1 fractions were filtered through 0.45 mm
filters, and the filtrates were loaded onto Ni2+-charged HisTrap
Chelating HP columns (GE Healthcare, Pittsburgh, PA) previously
equilibrated in buffer A supplemented to contain 5 mM imidazole.
Proteins were eluted with a linear gradient of imidazole from
5 mM to 500 mM using an A¨KTA chromatography system (GE
Healthcare). IN-containing fractions, which were identified
following sodium dodecyl sulfate–polyacrylamide gel electropho-
resis (SDS-PAGE) and staining with Coomassie blue, were
dialyzed overnight against 20 mM HEPES, pH 7.6, 50 mM
NaCl, 1 mM EDTA, 5 mM dithiothreitol (DTT) at 4uC.
Dialysates were then either loaded onto a HiTrap ANX anion
exchange column (GE Healthcare) or a HiTrap SP HP cation
exchange column (GE Healthcare), each pre-equilibrated with
20 mM HEPES, pH 7.6, 50 mM NaCl. INs were eluted from ion
exchange columns using a linear gradient of NaCl from 50 mM to
1 M. Fractions were detected as above.
LPDV and JSRV INs from fraction S3 were filtered through
0.45 mm filters, and filtrates were loaded onto HisTrap Chelating
HP columns pre-equilibrated with 20 mM HEPES pH 7.6,
200 mM NaCl, 8 M urea, 5 mM imidazole. Columns were
washed with 10 column volumes of buffer C adjusted to contain
8 M urea and 30 mM imidazole, and the INs were eluted by a
linear gradient of imidazole from 30 mM to 0.5 M. The INs were
refolded using one of three techniques: (i) rapid dilution (1:10) in
ice cold 20 mM HEPES, pH 7.6, 200 mM NaCl, 5 mM DTT, (ii)
successive dialysis to remove urea against: (a) 20 mM HEPES,
pH 7.6, 200 mM NaCl, 2 M urea, 10 mM CHAPS, 5 mM DTT,
1 mM EDTA, (b) 20 mM HEPES, pH 7.6, 200 mM NaCl, 1 M
urea, 10 mM CHAPS, 5 mM DTT, 1 mM EDTA, and (c)
20 mM HEPES, pH 7.6, 500 mM NaCl, 10 mM CHAPS, 5 mM
DTT, or (iii) directly on the column by gradient reduction of urea
from 8 to 0 M.
MMTV and Rev-A INs in fraction S2 were filtered through
0.45 mm filters, and filtrates were loaded onto Ni2+-charged
HisTrap Columns previously equilibrated with buffer B–20 mM
imidazole. Proteins were eluted by a linear gradient of imidazole
from 20 mM to 500 mM using the A¨KTA purifier system. IN
containing fractions, which were identified by Coomassie blue
staining after SDS-PAGE, were dialyzed against buffer B, and the
His6 tag was removed by cleavage with HRV 3C protease (GE
Healthcare) overnight at 4uC, yielding protein N-termini contain-
ing the heterologous Gly-Pro sequence. Cleaved MMTV and Rev-
A INs were purified by gel filtration on a Superdex 200 column
respectively equilibrated with buffer D (25 mM Tris-HCl, pH 7.4,
0.5 M NaCl, 5 mM CHAPS, 2 mM DTT) and buffer E (20 mM
HEPES, pH 7.6, 1 M NaCl, 2 mM CHAPS, 2 mM DTT).
Purified INs were concentrated by ultrafiltration using 10-kDa
molecular weight cutoff Millipore concentrators, and retentates
were dialyzed overnight against buffer D or buffer E, each
supplemented to contain 10% glycerol. Protein concentration was
determined by spectrophotometry, and aliquots flash-frozen in
liquid N2 were stored at –80uC. Protein purity was quantified by
analyzing silver-stained SDS-polyacrylamide gels using Molecular
ImagerH Gel DocTM XR+ System and Image Lab software (Bio-
Rad, Hercules, CA). The multimeric state of purified Rev-A and
MMTV IN proteins (200 mg) was analyzed by gel filtration
chromatography using a HiLoad 26/60 Superdex 200 column
Characterization of Novel Retroviral IN Proteins
PLOS ONE | www.plosone.org 2 October 2013 | Volume 8 | Issue 10 | e76638
equilibrated in 20 mM HEPES, pH 7.6, 1 M NaCl, 7.5 mM
CHAPS, 2 mM DTT.
Recombinant lens epithelium-derived growth factor (LEDGF)/
p75 [18] and human immunodeficiency virus type 1 (HIV-1) [19]
and PFV [8] IN proteins expressed in bacteria were purified as
previously described.
IN 39 processing activity assay
39 Processing substrates mimicked the U5 DNA ends of various
retroviruses. Oligonucleotide pairs AE4503/AE4505, AE4514/
AE4516, and AE191/AE143 represented MMTV, Rev-A, and
HIV-1 vDNAs, respectively, with one nucleotide omitted from the
39 ends of the transferred DNA strands. DNA duplexes, which
were annealed by heating for 3 min at 85uC in 100 mM NaCl,
were filled in with [a-32P]TTP (3,000 Ci/mmol; PerkinElmer,
Waltham, MA) using Sequenase version 2.0 T7 DNA polymerase
(GE Healthcare) [20]. Unincorporated radionucleotide was
removed by passing mixtures through Bio-Spin 6 columns (Bio-
Rad) equilibrated with 10 mM Tris-HCl, pH 8.0, 20 mM NaCl,
0.1 mM EDTA.
IN (0.5 mM) was incubated with 15 nM labeled DNA for 1 h at
37uC in 25 mM MOPS, pH 7.2, 10 mM DTT, 5 mM ZnSO4,
10 mM MgCl2 or MnCl2, with or without 10% glycerol in 20 mL.
The reaction was stopped by addition of 20 mL of sequencing gel
sample buffer (95% formamide, 10 mM EDTA, 0.003% xylene
cyanol, 0.003% bromophenol blue) and boiling for 2 min. DNA
(1 mL) was fractionated through denaturing 20% polyacrylamide
gels, and products visualized using a Storm 820 PhosphorImager
were quantified by ImageQuant version 1.2 (GE Healthcare).
DNA strand transfer activity assay
Substrates that mimicked preprocessed MMTV, Rev-A, HIV-1,
and PFV U5 vDNA ends for DNA strand transfer activity assays
were prepared by 59 end-labeling oligonucleotides AE4504,
AE4515, AE3653, and AE4468 with [c-32P]ATP (3,000Ci/mmol;
PerkinElmer) using Optikinase (Affymetrix, Santa Clara, CA) and
annealing unlabeled strands AE4505, AE4516, AE3652, and
AE4469, respectively. Unincorporated radionucleotide was re-
moved by passing the annealed vDNAs through Bio-Spin 6
columns as above.
IN (0.8 mM) was mixed with 0.5 mM vDNA, of which 5% was
59 end labeled, and 0.3 mg pGEM-3 target DNA in 20 mM
HEPES, pH 7.4, 32 mM NaCl, 5 mM MgCl2, 4 mM ZnSO4,
10 mM DTT in 40 mL. After 15 min at room temperature,
0.6 mM LEDGF/p75 was added to the HIV-1 IN-containing
reaction, then mixtures were incubated for 1 h at 37uC; reactions
were stopped by adding 25 mM EDTA–0.5% SDS. Products
deproteinized by digestion with proteinase K and precipitated with
ethanol were analyzed by electrophoresis through 1.5% agarose
gels, and DNAs were visualized using ethidium bromide (EtBr)
staining. After drying, radiolabeled DNA was visualized using a
Storm 820 PhosphorImager.
Table 1. Oligonucleotides used in this study.
Name Sequence Use Reference
AE191 59-TTTTAGTCAGTGTGGAAAATCTCTAGCAG HIV-1 U5 end –T (29-mer) [19]
AE143 59-ACTGCTAGAGATTTTCCACACTGACTAAAA HIV-1 U5 minus strand (30-mer) [19]
AE3652 59- ACTGCTAGAGATTTTCCACACTGACTAAAAGG HIV-1 U5 minus strand (32-mer) [19]
AE3653 59-CCTTTTAGTCAGTGTGGAAAATCTCTAGCA HIV-1 U5 end precleaved (30-mer) [19]
AE3715 59-GTGATATTGCTGAAGAGCTTG Integration site sequencing primer 1 This study
AE3717 59-ATTCCACAGCTGGTTCTTTC Integration site sequencing primer 2 This study
AE4468 59-ATTGTCATGGAATTTTGTATATTGATTATCCT PFV U5 end minus strand (EV54) [8]
AE4469 59-AGGATAATCAATATACAAAATTCCATGACA PFV U5 end preprocessed (EV55) [8]
AE4474 59-CAGGGACCCGGGGTACTCAAGAAGGGGGACGCC WDSV IN PCR primer1 This study
AE4475 59-GCGCGCAGATCTTAAGAAAGTAGCTGGTTGACTGG WDSV IN PCR primer2 This study
AE4484 59-CAGGGACCCGGGTCAGCTATTGATGCAGCCCGG JSRV IN PCR primer1 This study
AE4485 59-GCGCGCAGATCTCACTCGTGGGCTCGCTCAGC JSRV IN PCR primer2 This study
AE4494 59-CAGGGACCCGGGGCTTTAGAGTCAGCTCAAGAAAGC MMTV PCR primer1 This study
AE4495 59-GCGCGCAGATCTTAAGGACCTCCTCCGCTTCGG MMTV PCR primer 2 This study
AE4503 59-CGGTGACCCTCAGGTCGGCCGACTGCGGCAT MMTV U5 end –T (31-mer) This study
AE4504 59-CGGTGACCCTCAGGTCGGCCGACTGCGGCA MMTV U5 end precleaved (30-mer) This study
AE4505 59-AATGCCGCAGTCGGCCGACCTGAGGGTCACCG MMTV U5 end minus strand (32-mer) This study
AE4506 59-
GCGCGCCATATGCTTGAAGTCCTCTTTCAGGGACCCGATGCACCGGATATGCCAGATACC
Rev-A IN PCR primer1 This study
AE4507 59-GCGCGCAGATCTTAGGATTTTGCTCGCCTGGTCAAC Rev-A IN PCR primer2 This study
AE4514 59-GGACTGAATCCGTAGTACTTCGGTACAACAT Rev-A U5 end –T (31-mer) This study
AE4515 59-GGACTGAATCCGTAGTACTTCGGTACAACA Rev-A U5 end precleaved (30-mer) This study
AE4516 59-AATGTTGTACCGAAGTACTACGGATTCAGTCC Rev-A U5 end minus strand (32-mer) This study
AE5193 phospho-59-CAGGGCGCGTCAGGTGGCACT pEGFP-C1 PCR primer1 This study
AE5194 phospho-59-TTTCATAGAAGGCGGCGGTGG pEGFP-C1 PCR primer2 This study
doi:10.1371/journal.pone.0076638.t001
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Sequence analysis of Rev-A integration products
Integration products were cloned and sequenced essentially as
described previously for BIV and equine infectious anemia virus
IN [15]. Briefly, the strand transfer assay for Rev-A IN was scaled
up 30-fold using the unlabeled preprocessed vDNA substrate.
Integration products were separated on 1.5% agarose gels, and
linear DNA consistent with the concerted integration of two
vDNA ends was extracted using the Qiagen Gel Extraction kit;
DNA was eluted in 50 mL H2O. DNA precipitation by ethanol in
the presence of GenElute Linear PolyAcrylamide (Sigma-Aldrich,
St. Louis, MO) was resuspended in 10 mL H2O, treated with
Phi29 DNA polymerase (New England Biolabs, Beverly, MA) in
the presence of 200 mM dNTP, 50 mM Tris-HCl, pH 7.5,
10 mM MgCl2, 10 mM (NH4)2SO4, and 4 mM DTT, and 59-
phosphorylated using Optikinase in the presence of 1 mM ATP,
50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 5 mM DTT. A
kanamycin-resistance cassette prepared by PCR amplification of
pEGFP-C1 (Clontech, Mountain View, CA) using primers
AE5193 and AE5194 was digested with Dpn I to digest the
plasmid PCR template. DNA-repaired linear integration products
were ligated to the kanamycin-resistance cassette; E. coli DH5a
cells transformed with the ligation product were selected on agar
plates containing 35 mg/mL kanamycin. Plasmids extracted from
isolated colonies were sequenced using primers AE3715 and
AE3717.
Results
Experimental strategy
The utility of PFV IN in retroviral structural biology [4–6] can
be attributed to the solubility of the protein under conditions of
limited ionic strength [7,8] and the high efficiency of two-ended
concerted vDNA integration into target DNA in vitro [4,8].
Although the PFV intasome structures provide unprecedented
details on the mechanism of retroviral DNA integration, they are
based on a viral protein from a single genus of Retroviridae. Our
long-term goal is to expand the repertoire of retroviral intasome
structures and, toward this end, we have expressed five previously
uncharacterized IN proteins from four of the other six viral genera
in the hope of finding molecules with desirable protein solubility
and/or concerted integration activity profiles. The five proteins
are derived from the alpharetrovirus LPDV, betaretroviruses
MMTV and JSRV, epsilonretrovirus WDSV, and gammaretro-
virus Rev-A.
IN expression, solubility, and purification
IN proteins were engineered to be expressed as N-terminal His6
fusion proteins under the control of IPTG induction in bacteria.
The temperature and time of induction, as well as IPTG
concentration, was optimized for each expression construct,
yielding the following parameters: WDSV IN, 18uC, 16 h,
0.5 mM IPTG; LPDV IN, 18uC, 4 h, 0.3 mM IPTG; JSRV IN,
18uC, 4 h, 0.3 mM IPTG; MMTV IN, 37uC, 6 h, 0.5 mM IPTG;
Rev-A IN, 30uC, 16 h, 1 mM IPTG.
Figure 1. IN expression, extraction, and purification. (A) Fractions of bacterially expressed His6-tagged WDSV, LPDV, JSRV, MMTV, and Rev-A
INs were visualized through western blotting. Lanes 1 and 2 represent the pellet (P1) and supernatant (S1) fractions obtained following centrifugation
of cells lysed in 200 mM NaCl-containing buffer A. Pellet 2 (P2) and supernatant 2 (S2) were obtained following centrifugation (lanes 3 and 4) of
fraction P1 homogenized in buffer B containing 1 M NaCl and 5 mM CHAPS. During the final extraction step, the pellet from step 2 was homogenized
in buffer C containing 0.5 M NaCl and 2 M urea (lanes 5 and 6). (B) Schematic of the protocols utilized for JSRV, LPDV, MMTV, and Rev-A IN
purification. All columns were run on an A¨KTA purifier system. (C) The purities of MMTV (lane 2) and Rev-A (lane 4) INs were assessed at 93% and 97%,
respectively, following silver staining of SDS-polyacrylamide gels. Lanes 1 and 3 contain the indicated molecular mass standards.
doi:10.1371/journal.pone.0076638.g001
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The inherent solubility of each IN protein in E. coli extracts was
assessed by lysing the cells by sonication in buffer containing
relatively low salt concentration (200 mM NaCl), followed by
extraction in two subsequent buffers which contained reagents to
increasingly encourage protein solubilization (1 M NaCl–5 mM
CHAPS, followed by 0.5 M NaCl–2 M urea). This strategy
accordingly yielded six total fractions, three supernatants and three
derived from the pellets after centrifugation (Fig. 1A). Visualiza-
tion of SDS-polyacrylamide gels by western blotting revealed that
a fraction of expressed LPDV, JSRV, and Rev-A proteins was
solubilized following bacterial lysis in 200 mM NaCl-containing
buffer A, as some of each appeared in fraction S1. By contrast,
WDSV partitioned only to the pellet fractions (Fig. 1A). This
largely insoluble protein was not investigated further.
Several strategies were tested to purify the LPDV and JSRV INs
(Fig. 1B). Proteins extracted in buffer A were loaded onto Ni2+-
charged HisTrap Chelating HP columns, and the proteins were
eluted using a linear gradient of imidazole. Imidazole was
subsequently removed by dialysis, and the INs were loaded onto
anion or cation exchange columns, followed by elution using a
linear gradient of NaCl. JSRV IN was observed to precipitate
during this process, whereas LPDV IN did not effectively bind to
the initial Ni2+-chelating column. In an attempt to bypass protein
precipitation and to increase the yield of extracted protein, JSRV
IN extracted from pellet P2 in 2 M urea-containing buffer C was
purified by Ni2+-affinity chromatography in the presence of 8 M
urea and refolded either by dialysis or by rapid dilution, which in
both cases led to protein precipitation. LPDV IN from the
supernatant S3 (buffer C) fraction was similarly utilized to promote
binding to the Ni2+-affinity substrate. LPDV IN was subsequently
refolded directly on the column by decreasing the concentration of
urea in linear fashion, or after elution either by dialysis or by rapid
dilution. In all cases, LPDV IN precipitated out of solution.
Attempts to recover precipitated LPDV and JSRV IN proteins by
resuspension in buffer C were unsuccessful.
MMTV and Rev-A INs extracted in 1 M NaCl-containing
buffer B were loaded onto Ni2+-chelating columns and eluted
using linear gradients of imidazole. Excess imidazole was removed
by dialysis, and the His6 tag was removed by cleavage with the
HRV 3C protease. MMTV and Rev-A INs were further purified
by gel filtration chromatography, and then concentrated by
ultrafiltration (Fig. 1B).
Highly purified (97%) Rev-A IN (2 mg) was recovered from 2 L
of E. coli culture (1 mg/6 g of bacteria), while about 4 mg of
MMTV IN (93% pure) was recovered from 4 L of culture (1 mg/
4 g of bacteria) (Fig. 1C). Gel filtration analysis of the concentrated
preparations revealed that Rev-A and MMTV INs migrated
predominantly as monomers, with secondary species consistent
with dimeric IN protein (Fig. S1).
39 Processing of vDNA ends
IN activity requires divalent metal ion cofactor, such as Mg2+ or
Mn2+ [21,22]. The activities of purified Rev-A and MMTV IN
proteins were assessed under different reaction conditions.
Initially, 39 processing activity was measured using duplex
oligonucleotides labeled within the dinucleotide that is cleaved
by the IN protein (Fig. 2A). The 39 ends of the vDNA plus-strands
of MMTV and Rev-A terminate in TT, so 39 processing of the
DNA ends accordingly releases labeled pTTOH cleavage products,
which are readily assessed following denaturing polyacrylamide
electrophoresis (Fig. 2B). As the 39 end of the HIV-1 plus-strand
terminates GT, pGTOH is produced in this reaction.
In the presence of either Mg2+ or Mn2+ cofactor, MMTV and
Rev-A INs processed their respective vDNA substrates (Fig. 2B,
lanes 6–10 and 11–15). HIV-1 IN, used as a control, similarly
processed its substrate (Fig. 2B, lanes 1–5). As previously
established [20], HIV-1 IN generated the 39–59 cyclic dinucleotide
product, also referred to as form II product, in the presence of
Mn2+ (Fig. 2B, barely detected at this exposure level, lanes 4 and
5). Glycerol can also be used as an alternative nucleophilic agent
instead of water, leading to formation of a glycerol dinucleotide
adduct (also called form I cleavage product), and the alcoholysis
pathway is likewise stimulated by Mn2+ [23]. Whereas the form I
product dominated over form II in Mn2+-dependent reaction
conditions with HIV-1 IN [20], Mn2+ preferentially stimulated the
formation of form II over form I for both MMTV and Rev-A INs
(Fig. 2B, lanes 4, 5, 9, 10, 14, and 15). We note a similar
preference for the formation of the form II cyclic cleavage product
in Mn2+-dependent 39 processing reactions with the gammare-
troviral IN protein from Moloney murine leukemia virus (MLV)
[24].
HIV-1 IN 39 processing activity was more efficient than either
MMTV or Rev-A IN in the presence of Mg2+ (34% of the HIV-1
substrate processed in the absence of glycerol, compared to 9%
and 3% for MMTV and Rev-A, respectively). Whereas glycerol
afforded the altered choice of nucleophile in the presence of Mn2+,
it did not significantly stimulate the overall extent of substrate
processing under any condition tested. By contrast, Rev-A 39
processing activity was stimulated significantly by Mn2+ (Fig. 2C).
DNA strand transfer activity
The DNA strand transfer activity assay was designed to monitor
the extent of concerted vDNA integration in addition to the
integration of single vDNA ends into target DNA (Fig. 3A). Pre-
processed, 59-end labeled DNAs that mimic the U5 ends of the
various viruses were incubated with pGEM-3 circular plasmid
DNA as the integration target. The integration of a single vDNA
end into one strand of target DNA yields a tagged circular product
that co-migrates with the open circular plasmid DNA molecule,
whereas concerted integration yields a linear product that migrates
close to the linearized form of the plasmid (,3 kb) (Fig. 3A). HIV-
1 IN and PFV IN were used as positive controls. As expected,
HIV-1 IN yielded only half-site integration products in the
absence of additional protein co-factors (Fig. 3B, lane 8); the
addition of the LEDGF/p75 co-factor increased the overall extent
of IN activity, and significantly stimulated the formation of
concerted vDNA integration products (Fig. 3B, lane 10) [25]. PFV
IN, also as expected, generated a predominance of concerted
integration products in the absence of IN-binding co-factors (Fig.
3B, lane 6) [4,8]. MMTV and Rev-A INs also preferentially
catalyzed the concerted integration of two vDNA ends over the
half site integration of a single vDNA into target DNA (Fig. 3B,
lanes 2 and 4; exemplified in the lower phosphorImager panel).
Under these reaction conditions, MMTV IN converted about
1.4% and 0.8% of the substrate into concerted and half-site
integration products, respectively, while ,0.9% and 0.3% were
generated by Rev-A IN (Fig. 3C).
Sequence analysis of Rev-A concerted integration
products
Both MMTV and Rev-A INs catalyzed 39 processing and
concerted vDNA strand transfer activities, and thus could be good
structural biology candidates. The integration site preferences of
MMTV have been analyzed extensively in virus-infected cells
[26], whereas only a handful (8 total) of integration sites have been
reported for spleen necrosis virus (SNV) [27,28], an avian
gammaretrovirus that is closely related to Rev-A [29]. Because
the limited number of proviruses precluded the assessment of
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nucleotide preferences at the sites of SNV integration in cells [28],
we cloned and sequenced products of in vitro concerted Rev-A
DNA integration reactions to more fully characterize the
integration mechanism of this species of gammaretrovirus. The
linear DNA products, which were treated with the strand-
displacing Phi29 DNA polymerase and phosphorylated, were
ligated to a blunt-ended kanamycin resistance cassette prior to
transformation of E. coli cells. Plasmids extracted from isolated
colonies were sequenced using outward facing primers that
annealed to the flanking regions of the kanamycin cassette; Table
2 summarizes the different types of integration products obtained.
Although a significant number of recovered DNA products
contained only a single viral DNA end, all products of concerted
vDNA integration notably harbored a duplication of 5 bp of target
DNA sequence.
Target DNA nucleotides in the immediate vicinity of the Rev-A
concerted DNA integration sites were analyzed by comparing the
observed frequencies to the expected frequencies at each position
based on the sequence of the pGEM-3 target DNA, which is
24.8% A, 25.8% C, 25.3% G, and 24.1% T (Fig. 4A). Using the
nomenclature recommended by the International Union of Pure
and Applied Chemistry-International Union of Biochemistry
(IUPAC-IUB) [30], the following consensus sequence was
ascribed: (T/H)NQ(A/V)(T/H)W(A/D)(T/B)N(A/D) (the arrow
indicates the position of plus-strand joining; the underline indicates
the sequence of 5 bp duplication).
Discussion
In this study five previously uncharacterized retroviral IN
proteins were analyzed following their expression in bacteria. Our
long-term goal is generating 3-dimensional structures of retroviral
intasome complexes. Toward this end, the goal of this study was to
characterize the inherent solubilities and concerted integration
activities of the novel IN proteins.
Our results show that epsilonretrovirus WDSV IN is not soluble
under the tested conditions, which included induction of protein
expression in E. coli cultures propagated at 18uC. Epsilonretrovirus
is the only retroviral genus for which an IN protein has not
previously been characterized. It has been suggested that WDSV
reverse transcriptase is temperature sensitive, displaying optimal
Figure 2. IN 39 processing activities. (A) Schematic of blunt-ended vDNA substrate processed by IN adjacent to the conserved CA 39 dinucleotide
(vertical arrowhead). Positions of 32P label are shown by *. (B) Polyacrylamide sequencing gel of products of HIV-1, MMTV, and Rev-A IN 39 processing
reactions; Mn2+, Mg2+, and glycerol were included as indicated. The positions of the starting substrates (30 bp for HIV-1 IN; 32 bp for MMTV and Rev-
A), the simple dinucleotide cleavage products (pGpTOH for HIV-1 and pTpTOH for MMTV and Rev-A), and form I and form II cleavage products are
indicated. IN proteins were omitted from the initial reaction in each set of five reactions. (C) Mn2+ and Mg2+-dependent 39 processing activities
expressed as percentage of product formation 6 standard error of the mean (SEM) for three independent experiments. Asterisks indicate P values
,0.05 by paired t-test.
doi:10.1371/journal.pone.0076638.g002
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activity at 4–15uC, which might reflect the natural habitat of the
fish host [31]. We can hypothesize that WDSV IN might also be
temperature sensitive, and that our tested conditions did not satisfy
its parameters for proper folding when expressed in bacteria.
We were able to express and extract alpharetrovirus LPDV IN,
betaretrovirus JSRV IN and MMTV IN, and gammaretrovirus
Rev-A IN. However, despite extensive effort (Fig. 1B), we were
unable to purify accountable amounts of either LPDV or JSRV
IN. It could be useful to test different expression systems, for
example baculovirus in insect cells, to see if the biophysical
properties of these INs might improve during purification. Due to
our long-term goal, we have focused in this study on activity
characterization of proteins that could be recovered from bacterial
extracts. By monitoring 39 processing and DNA strand transfer
Figure 3. Concerted integration assay design and IN activities. (A) Schematic showing precleaved U5 substrate (vDNA), circular plasmid
target DNA (pGEM-3), and products of single-end versus concerted vDNA integration. Positions of 32P label are shown by *. (B) EtBr stained image
(upper panel) and phosphorimage (lower panel) of integration reactions, comparing MMTV and Rev-A INs to control PFV and HIV-1 IN proteins.
Reactions fractionated through two separate gels delimitated by a white border were performed under the exact same conditions. Half-site products
of Rev-A and PFV vDNA integration were evident upon long exposure of the phosphorImager screen. Migration positions of standards (in kb) are
shown to the left, whereas positions of half-site and concerted vDNA integration products are to the right. Note the half-site products co-migrate
with the open circular (o.c.) form of pGEM-3, whereas the concerted products migrate in between the o.c. and supercoiled (s.c.) forms of the plasmid.
(C) Half-site and concerted integration quantification of panel B phosphorimage. Results (percent of vDNA substrate converted into half-site and
concerted integration reaction products) are means 6 SEM for three independent experiments.
doi:10.1371/journal.pone.0076638.g003
Table 2. Rev-A integration products obtained by DNA
sequence analysis.
Type of integration product Number of colonies
Concerted integration with 5 bp duplication 26
Concerted integration with duplication other
than 5 bp
,1
Half-site integration 13
Multiple half-site integrations 4
doi:10.1371/journal.pone.0076638.t002
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activities, we show that MMTV and Rev-A INs each preferentially
catalyze the concerted integration of two vDNA ends into target
DNA under conditions, that in the absence of the LEDGF/p75
co-factor, favored HIV-1 IN half-site integration activity (Fig. 3B).
Based on observations that PFV IN is primarily monomeric in
solution [4,7] and that HIV-1 IN monomers can catalyze
proficient concerted integration activity in the absence of
LEDGF/p75 protein [32], there is some reason to believe that
monomers serve as obligate intermediates in intasome assembly.
Our results with MMTV and Rev-A INs are consistent with this
hypothesis, as both proteins predominantly migrated as monomers
on a gel filtration column (Fig. S1) and also preferentially catalyzed
concerted integration activity in vitro (Fig. 3).
Retroviridae is classified into seven genera [33]. Except for
epsilonretroviruses, integration site preferences are known for at
least one member of each genus, which has further led to the
classification of the viral INs into three clusters. Each cluster is
characterized by integration site preference and length of target
site duplication, as well as IN sequence phylogeny: (i) near
transcription start sites and CpG islands, generation of a 4 bp
duplication (the gammaretrovirus and spumavirus MLV and PFV,
respectively); (ii) within genes or transcription units, 5 bp
duplication (the lentiviruses); (iii) randomly dispersed, 6 bp
duplication (alpharetrovirus avian sarcoma-leukosis virus, betare-
trovirus MMTV, and deltaretrovirus human T-cell leukemia virus)
[26,34,35]. According to this classification and knowing that MLV
and Rev-A gammaretroviral INs are 40.4% identical and 59.6%
similar at the amino acid level (Fig. S2), we would have predicted a
4 bp duplication of target DNA following concerted Rev-A
integration, yet a 5 bp duplication was observed (Fig. 4A). Of note,
the 5 bp duplication is consistent with that observed for SNV in
cell culture [27,28].
Based on prior work with PFV IN, we conjecture that the
preference for particular bases at the sites of integration is dictated
by IN-target DNA interactions [5]. Accordingly, both MLV and
Rev-A appear to select for similar base contacts during integration
(Fig. 4B). The key difference between these site preferences is that
Rev-A IN yields the 5 bp (A/V)(T/H)W(A/D)(T/B) target site
duplication where MLV IN generates the 4 bp VTAB duplication
(Fig. 4B). Our results therefore clarify that the spacing of the cut in
target DNA across the major groove is apparently more
evolutionarily flexible than are the gammaretroviral IN-target
DNA contacts during integration.
Conclusions
From five initially studied novel retroviral IN proteins, Rev-A
IN and MMTV IN were produced in reasonable yields from E.
coli, and preferentially catalyzed concerted vDNA integration in
vitro. Rev-A IN and MMTV IN have accordingly been selected for
our structural biology pipeline. Our results also highlight that
different viruses from the same retroviral genus (the gammare-
troviruses in this case) can produce different sized duplications of
host DNA sequence flanking their integrated proviruses. This
information should be taken into account when using integration-
Figure 4. Sequence analysis of Rev-A integration sites and comparison to MLV. (A) Palindromic consensus sequence from sites of Rev-A
integration in vitro. Observed frequencies of nucleotides at the insertion sites were compared to expected frequencies at each position based on the
sequence of the pGEM-3 target DNA. The sequence of the target site duplication following DNA gap repair is indicated in the black box and
underlined below the consensus sequence, which employs IUPAC-IUB nucleotide codes; positions of DNA strand transfer are labeled by vertical
arrows. Green and red boxes highlight nucleotide positions that are .140% and ,60% of the expected base, respectively. Yellow boxes and bold
values indicate P values of ,0.05 and 0.001, respectively. (B) Comparison of consensus Rev-A (from panel A) and MLV [36] integration site sequences.
doi:10.1371/journal.pone.0076638.g004
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specific parameters to classify different retroviruses into clusters or
groups [26,34,35].
Supporting Information
Figure S1 Gel filtration chromatography analysis of
purified MMTV and Rev-A IN proteins. Based on the
calibration curve calculated from the elution volumes of the noted
globular protein standards, the predominant MMTV and Rev-A
IN species migrated at ,58 kDa and 60 kDa, respectively, while
their calculated molecular weights are 35.6 kDa and 44.6 kDa,
respectively. Vo, void volume; mAU, milli absorbance unit.
(TIF)
Figure S2 Comparison of Rev-A and MLV IN proteins.
Alignment of MLV and Rev-A IN sequences generated using
ESPript [37]. Red and yellow boxes indicate positions of amino
acid identity and similarity, respectively.
(TIF)
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